Biocon Quarterly Results

Charts

YoY Net Sales (Quarterly)

Operating Margin

EPS Growth

POSITIVES

Recent quarter shows strong revenue growth of 10.5% YoY, indicating robust market demand.
Operating profit margin surged to 9.72% in Q2 2024, reflecting improved cost management.
Net profit rebounded to ₹81.10 Crore in Q4 2024 from ₹27.10 Crore in Q3, signaling recovery.

NEGATIVES

Net profit dropped significantly from ₹861.80 Crore in Q2 2024 to ₹27.10 Crore in Q3, raising concerns.
Expenses increased due to higher material costs, impacting profitability.
Quarterly revenue decline in Q2 2024 suggests potential seasonal volatility in demand.

Field	Jun 23	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	3,422.60	3,462.30	3,953.70	3,917.10	3,432.90	3,590.40	3,821.40	4,417	3,941.90
Expenses	2,708.20	2,720.70	3,026.90	3,001.20	2,812.50	2,905	3,069.60	3,338.80	3,193
Operating Profit	714.40	741.60	926.80	915.90	620.40	685.40	751.80	1,078.20	748.90
Other Income	93.50	157.90	565.50	48.60	1,134.50	32.50	34.80	36.90	79.70
Interest	233	247.70	266.70	227	236	225.60	223.40	212.40	276.70
Depreciation	358	389.30	414.50	407	405.40	419.90	425.40	436.30	455
Profit Before Tax	183.70	214.30	808.20	319	1,145.50	98.40	155.90	486.80	96.90
Tax	34.80	41.60	54.90	96.10	283.70	71.30	74.80	27.40	7.70
Net Profit	148.90	172.70	753.30	222.90	861.80	27.10	81.10	459.40	89.20
Eps in Rs	0.85	1.05	5.52	1.13	5.51	-0.13	0.21	2.88	0.26